skip to main content

LABA safety — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

ModerateRespiratory TherapeuticsLABA safetyGPhC CRA

A prescription for salmeterol inhaler is received for a patient with asthma. The medication history shows no inhaled corticosteroid. The patient says it is for regular daily use. What is the most appropriate alternative?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: A — Query LABA use without inhaled corticosteroid cover

Long-acting beta2 agonists should not be used without inhaled corticosteroid therapy in asthma because of safety concerns and inadequate control of inflammation. Salmeterol is not a reliever for acute symptoms. The prescription should be clarified before supply. Dose escalation without review would be unsafe.

Reference: https://www.pharmacyregulation.org/registration-assessment#stage-8-order-33